[1] WEISS SR, LEIBOWITZ JL.Coronavirus pathogenesis[J]. Adv Virus Res, 2011, 59(81): 85-164. [2] LUO YB, WU Y, LU M, et al.Thoughts on the strategy and mechanism of normalized prevention and control of COVID-19[J]. Public Health and Preventive Medicine(公共卫生与预防医学), 2020, 31(6): 1-5. [3] GIANNIS D, ZIOGAS IA, GIANNI P.Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past[J]. J Clin Virol, 2020, 23(4): 104362. [4] ACKERMANN M, VERLEDEN SE, KUEHNEL M, et al.Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19[J]. N Engl J Med, 2020, 383(2): 120-128. [5] PELLICORI P, DOOLUB G, WONG CM, et al.Novel coronavirus pneumonia and its cardiovascular effects: a systematic review of epidemiological studies[J]. Chinese Journal of Hypertension(中华高血压杂志), 2021, 29(5): 499. [6] GUAN WJ, Ni ZY, HU Y, et al.Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020, 382(18): 1708-1720. [7] DI MINNO A, AMBROSINO P, CALCATERRA I, et al.COVID-19 and venous thromboembolism: a meta-analysis of literature studies[J]. Semin Thromb Hemost, 2020, 46(7): 763-771. [8] LI Y, LI M, WANG M, et al.Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study[J].Stroke Vasc Neurol, 2020, 5(3): 279-284. [9] UMAPATHI T, KOR AC, VENKETASUBRAMANIAN N, et al.Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)[J]. J Neurol, 2004, 251(10): 1227-1231. [10] ASSIRI A, ALTAWFIQ JA, ALRABEEAH AA, et al.Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study[J]. Lancet Infect Dis, 2013, 13(9): 752-761. [11] CAMPOROTA L, CRONIN JN, BUSANA M, et al.Pathophysiology of coronavirus-19 disease acute lung injury[J]. Curr Opin Crit Care, 2022, 28(1): 9-16. [12] LIM MS, MCRAE S.COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications[J]. Crit Rev Oncol Hematol, 2021, 168: 103529. [13] MARUHASHI T, HIGASHI Y.Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19[J]. Int J Mol Sci, 2021, 22(10): 5131. [14] BOSCHI C, SCHEIM DE, BANCOD A, et al.SARS-CoV-2 spike protein induces hemagglutination: implications for COVID-19 morbidities and therapeutics and for vaccine adverse effects[J]. Int J Mol Sci, 2022, 23(24): 15480. [15] HAO W, MA B, LI Z, et al.Binding of the SARS-CoV-2 spike protein to glycans[J]. Sci Bull (Beijing), 2021, 66(12): 1205-1214. [16] REZAIE AR.Protease-activated receptor signalling by coagulation proteases in endothelial cells[J]. Thromb Haemost, 2014, 112(5): 876-882. [17] VERAS FP, PONTELLI MC, SILVA CM, et al.SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology[J]. J Exp Med, 2020, 217(12): e20201129. [18] FUCHS TA, BRILL A, DUERSCHMIED D, et al.Extracellular DNA traps promote thrombosis[J]. Proc Natl Acad Sci USA, 2010, 107(36): 15880-15885. [19] LO MW, KEMPER C, WOODRUFF TM.COVID-19: complement, coagulation, and collateral Damage[J]. J Immunol, 2020, 205(6): 1488-1495. [20] SUBRAMANIAM S, JURK K, HOBOHM L, et al.Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development[J]. Blood, 2017, 129(16): 2291-2302. [21] WOJTA J, HUBER K, VALENT P.New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype[J]. Pathophysiol Haemost Thromb, 2003, 33(5-6): 438-441. [22] HAMMING I, TIMENS W, BULTHUIS ML, et al.Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis[J]. J Pathol, 2004, 203(2): 631-637. [23] JARAJAPU YPR.Targeting angiotensin-converting enzyme-2/angiotensin-(1-7)/mas receptor axis in the vascular progenitor cells for cardiovascular diseases[J]. Mol Pharmacol, 2021, 99(1): 29-38. [24] CUI S, CHEN S, LI X, et al.Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia[J]. J Thromb Haemost, 2020, 18(6): 1421-1424. [25] VARGA Z, FLAMMER AJ, STEIGER P, et al.Endothelial cell infection and endotheliitis in COVID-19[J]. Lancet, 2020, 395(10234): 1417-1418. [26] ACKERMANN M, VERLEDEN SE, KUEHNEL M, et al.Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19[J]. N Engl J Med, 2020, 383(2): 120-128. [27] MILLER SE.Visualization of SARS-CoV-2 in the Lung[J]. N Engl J Med , 2020, 383(27):2689. [28] PATEL BV, ARACHCHILLAGE DJ, RIDGE CA, et al.Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations[J]. Am J Respir Crit Care Med, 2020, 202(5): 690-699. [29] PERICO L, MORIGI M, GALBUSERA M, et al.SARS-CoV-2 spike protein 1 activates microvascular endothelial cells and complement system leading to platelet aggregation[J]. Front Immunol, 2022, 13: 827146. [30] ZUCHI C, TRITTO I, CARLUCCIO E, et al.Role of endothelial dysfunction in heart failure[J]. Heart Fail Rev, 2020, 25(1): 21-30. [31] ZHOU Z, CONNELL MC, MACEWAN DJ.TNFR1-induced NF-kappaB, but not ERK, p38 MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells[J]. Cell Signal, 2007, 19(6): 1238-1248. [32] ZHANG G, QIN Q, ZHANG C, et al.NDRG1 signaling is essential for endothelial inflammation and vascular remodeling[J]. Circ Res, 2023, 132(3): 306-319. [33] BECKMAN JD, DASILVA A, ARONOVICH E, et al.JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions[J]. J Thromb Haemost, 2023, 21(5): 1366-1380. [34] DING HM, LI YJ, HUA XQ, et al.Research progress on the mechanism of ischemic stroke caused by SARS-CoV-2[J]. Chinese Journal of Virology(病毒学报), 2023, 39(1): 231-237. [35] JIN Q, SU H, YANG R, et al.C1q/TNF-related protein-9 ameliorates hypoxia-induced pulmonary hypertension by regulating secretion of endothelin-1 and nitric oxide mediated by AMPK in rats[J]. Sci Rep, 2021, 11(1): 11372. [36] PATTERSON EK, CEPINSKAS G, FRASER DD.Endothelial glycocalyx degradation in critical illness and injury[J]. Front Med (Lausanne), 2022, 9: 898592. [37] MYLVAGANAM S, PLUMB J, YUSUF B, et al.The spectrin cytoskeleton integrates endothelial mechanoresponses[J]. Nat Cell Biol, 2022, 24(8): 1226-1238. [38] YAMAOKA-TOJO M.Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19[J]. Biomed J, 2020, 43(5): 399-413. [39] KOUPENOVA M, CORKREY HA, VITSEVA O, et al.The role of platelets in mediating a response to human influenza infection[J]. Nat Commun, 2019, 10(1): 1780. [40] COLLING ME, TOURDOT BE, KANTHI Y.Inflammation, infection and venous thromboembolism[J]. Circ Res, 2021, 128(12): 2017-2036. [41] MANNE BK, DENORME F, MIDDLETON EA, et al.Platelet gene expression and function in patients with COVID-19[J]. Blood, 2020, 136(11): 1317-1329. [42] ZOU Z, YANG Y, CHEN J, et al.Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases[J]. Clin Infect Dis, 2004, 38(4): 483-489. [43] KOUPENOVA M, CORKREY HA, VITSEVA O, et al.The role of platelets in mediating a response to human influenza infection[J]. Nat Commun, 2019, 10(1): 1780. [44] SKENDROS P, MITSIOS A,CHRYSANTHOPOULOU A, et al.Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis[J]. J Clin Invest, 2020, 130(11): 6151-6157. [45] RUAN CC, GE Q, LI Y, et al.Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice[J]. Arterioscler Thromb Vasc Biol, 2015, 35(3): 598-606. [46] ISRAELOW B, SONG E, MAO T, et al.Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling[J]. JExp Med, 2020,125(12): 20201241. [47] BRUMBACK BD, DMYTRENKO O, ROBINSON AN, et al.Human cardiac pericytes are susceptible to SARS-CoV-2 infection[J]. JACC Basic Transl Sci, 2023, 8(2): 109-120. [48] ZHANG L, LI YH, KIBLER K, et al.Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection[J]. EMBO Mol Med, 2023, 15(9): e17376. [49] SEFIK E, ISRAELOW B, MIRZA H, et al.A humanized mouse model of chronic COVID-19[J]. Nat Biotechnol, 2022, 40(6): 906-920. |